A detailed history of Virtus ETF Advisers LLC transactions in Bio N Tech Se stock. As of the latest transaction made, Virtus ETF Advisers LLC holds 3,431 shares of BNTX stock, worth $400,912. This represents 0.2% of its overall portfolio holdings.

Number of Shares
3,431
Previous 3,431 -0.0%
Holding current value
$400,912
Previous $275,000 48.0%
% of portfolio
0.2%
Previous 0.14%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$80.36 - $102.87 $18,804 - $24,071
-234 Reduced 6.38%
3,431 $275,000
Q1 2024

May 15, 2024

BUY
$88.96 - $112.35 $46,881 - $59,208
527 Added 16.79%
3,665 $338,000
Q4 2023

Feb 15, 2024

BUY
$90.91 - $112.75 $36,182 - $44,874
398 Added 14.53%
3,138 $331,000
Q3 2023

Nov 07, 2023

SELL
$98.5 - $125.08 $35,164 - $44,653
-357 Reduced 11.53%
2,740 $297,000
Q2 2023

Aug 14, 2023

BUY
$102.58 - $129.66 $147,920 - $186,969
1,442 Added 87.13%
3,097 $334,000
Q1 2023

May 15, 2023

BUY
$122.57 - $153.67 $3,554 - $4,456
29 Added 1.78%
1,655 $206,000
Q4 2022

Feb 14, 2023

SELL
$118.43 - $186.05 $14,330 - $22,512
-121 Reduced 6.93%
1,626 $244,000
Q3 2022

Nov 14, 2022

BUY
$127.65 - $183.11 $3,318 - $4,760
26 Added 1.51%
1,747 $236,000
Q2 2022

Aug 12, 2022

BUY
$123.25 - $186.24 $46,465 - $70,212
377 Added 28.05%
1,721 $257,000
Q4 2021

Feb 14, 2022

SELL
$216.64 - $362.52 $157,930 - $264,277
-729 Reduced 35.17%
1,344 $346,000
Q3 2021

Nov 15, 2021

SELL
$205.93 - $447.23 $39,332 - $85,420
-191 Reduced 8.44%
2,073 $566,000
Q2 2021

Aug 10, 2021

SELL
$113.32 - $241.49 $398,319 - $848,837
-3,515 Reduced 60.82%
2,264 $507,000
Q1 2021

May 17, 2021

BUY
$85.73 - $119.5 $13,545 - $18,881
158 Added 2.81%
5,779 $631,000
Q4 2020

Feb 12, 2021

SELL
$72.71 - $129.54 $53,950 - $96,118
-742 Reduced 11.66%
5,621 $458,000
Q3 2020

Nov 13, 2020

SELL
$57.81 - $104.17 $49,080 - $88,440
-849 Reduced 11.77%
6,363 $441,000
Q2 2020

Aug 05, 2020

BUY
$38.58 - $66.74 $278,238 - $481,328
7,212 New
7,212 $481,000

Others Institutions Holding BNTX

About BioNTech SE


  • Ticker BNTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 242,684,992
  • Market Cap $28.4B
  • Description
  • BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...
More about BNTX
Track This Portfolio

Track Virtus ETF Advisers LLC Portfolio

Follow Virtus ETF Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus ETF Advisers LLC with notifications on news.